Published on FiercePharma (http://www.fiercepharma.com)

SPOTLIGHT: Will Rituxan be next MS breakthrough?

By admin

Created Feb 14 2008 - 6:59am

The cancer drug Rituxan cut multiple sclerosis lesions and relapses in a small clinical trial; its developers, Genentech and Biogen Idec, hope to establish its efficacy in larger trials. Report [1]

Biogen Idec
Genentech

Source URL: http://www.fiercepharma.com/story/spotlight-will-rituxan-be-next-ms-breakthrough/2008-02-14

Links:
[1] http://www.sfgate.com/cgi-bin/article.cgi?f=/c/a/2008/02/14/BU7GV1LEF.DTL